- Home
- TKR vs GH Comparison
TKR vs GH Comparison
Compare TKR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKR
- GH
- Stock Information
- Founded
- TKR 1899
- GH 2011
- Country
- TKR United States
- GH United States
- Employees
- TKR N/A
- GH N/A
- Industry
- TKR Metal Fabrications
- GH Medical Specialities
- Sector
- TKR Industrials
- GH Health Care
- Exchange
- TKR Nasdaq
- GH Nasdaq
- Market Cap
- TKR 5.1B
- GH 4.9B
- IPO Year
- TKR N/A
- GH 2018
- Fundamental
- Price
- TKR $77.82
- GH $60.13
- Analyst Decision
- TKR Buy
- GH Strong Buy
- Analyst Count
- TKR 10
- GH 17
- Target Price
- TKR $79.56
- GH $58.24
- AVG Volume (30 Days)
- TKR 598.6K
- GH 2.5M
- Earning Date
- TKR 11-04-2025
- GH 11-05-2025
- Dividend Yield
- TKR 1.80%
- GH N/A
- EPS Growth
- TKR N/A
- GH N/A
- EPS
- TKR 4.40
- GH N/A
- Revenue
- TKR $4,514,100,000.00
- GH $828,849,000.00
- Revenue This Year
- TKR N/A
- GH $28.07
- Revenue Next Year
- TKR $3.14
- GH $21.61
- P/E Ratio
- TKR $17.64
- GH N/A
- Revenue Growth
- TKR N/A
- GH 28.74
- 52 Week Low
- TKR $56.20
- GH $20.14
- 52 Week High
- TKR $87.52
- GH $68.00
- Technical
- Relative Strength Index (RSI)
- TKR 52.75
- GH 54.70
- Support Level
- TKR $74.70
- GH $57.50
- Resistance Level
- TKR $79.78
- GH $68.00
- Average True Range (ATR)
- TKR 1.62
- GH 2.28
- MACD
- TKR -0.07
- GH -0.36
- Stochastic Oscillator
- TKR 61.30
- GH 25.68
About TKR Timken Company (The)
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.